Unlabelled: Subjective Memory Complaints (SMC) are frequent among adults and elderly and are associated with poor quality of life. The etiology and clinical significance of SMCs are unclear, but these complaints are associated with objective cognitive decline or with depression, anxiety and psychosocial stressors. Biological and physiological brain alterations resembling those in Alzheimer's Disease have been found in SMC. SMC can evolve with different outcomes and represent the initial symptom or a risk factor of dementia. Active systematic search can be useful for early screening of candidates for preventive or therapeutic interventions.
Objective: To propose a Memory Complaints Scale (MCS) as an instrument for actively searching for memory complaints and to investigate its utility for discriminating demented from cognitively normal elderly.
Methods: A total of 161 patients from a teaching behavioral neurology outpatient unit of a tertiary hospital were studied. The MCS was used in two ways, by direct application to the patient and by application to the patient's companion. Cognitive tests assessing depression and daily living activities were also applied.
Results: High Cronbach's alpha coefficients were found for the two application methods. Correlations between the two versions and the other instruments administered for patients grouped by type and severity of dementia were also found.
Conclusion: The MCS is a useful scale for identifying memory complaints and discriminating demented from cognitively normal elderly. Further studies confirming these findings are warranted.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5619332 | PMC |
http://dx.doi.org/10.1590/S1980-57642012DN06040004 | DOI Listing |
Int J Environ Res Public Health
December 2024
Neurology Department, Fundación Valle del Lili, Carrera 98 No. 18-49, Cali 760032, Colombia.
Falls are a public health problem, impacting quality of life, independence, and health costs. Subjective memory complaints (SMCs) and mild cognitive impairment (MCI) increase with age and may coexist. The risk of falls coinciding with SMCs is less understood.
View Article and Find Full Text PDFBiomolecules
December 2024
Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences, Oklahoma City, OK 73117, USA.
Mild cognitive impairment (MCI) affects nearly 20% of older adults worldwide, with no targetable interventions for prevention. COVID-19 adversely affects cognition, with >70% of older adults with Long COVID presenting with cognitive complaints. Neurovascular coupling (NVC), an essential mechanism of cognitive function, declines with aging and is further attenuated in neurocognitive disorders.
View Article and Find Full Text PDFCNS Spectr
January 2025
ETSIDI-Center for Automation and Robotics UPM-CSIC, Universidad Politécnica de Madrid, Madrid, Spain.
J Ethnopharmacol
December 2024
Engineering Research Center of TCM Protection Technology and New Product Development for the Elderly Brain Health, Ministry of Education, Hubei University of Chinese Medicine, Wuhan, 430065, China; Key Laboratory of Chinese Medicine Resource and Compound Prescription, Ministry of Education, Hubei University of Chinese Medicine, Wuhan 430065, China. Electronic address:
J Pharmacopuncture
December 2024
College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea.
Objectives: Subjective memory complaints, increasingly common among older adults, may indicate early cognitive decline or dementia. , a herbal medicine in Korean medicine, has shown potential cognitive benefits in preclinical studies through neuroprotective and anti-inflammatory properties. Given limited efficacy of current pharmacological treatments for cognitive impairment and growing interest in natural products, investigating extract in humans is warranted.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!